Phase Ib trial of TRC-105 in combination with regorafenib [Stivarga] in patients with colorectal cancer

Trial Profile

Phase Ib trial of TRC-105 in combination with regorafenib [Stivarga] in patients with colorectal cancer

Planning
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2015

At a glance

  • Drugs Carotuximab (Primary) ; Regorafenib
  • Indications Colorectal cancer
  • Focus Adverse reactions
  • Sponsors Acerus Pharmaceuticals
  • Most Recent Events

    • 07 Aug 2015 New trial record
    • 05 Aug 2015 According to a TRACON Pharmaceuticals media release, this trial is expected to be initiated before the end of 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top